No registry, health agency, or peer-reviewed study has yet confirmed a specific number of cancers caused by vaping. That is not because the evidence says vaping is safe. It is because most cancers take decades to develop after an exposure begins, and widespread e-cigarette use only started around 2010-2012. A 2025 systematic review found no significant incident or prevalent cancer risk in never-smoker vapers, but it also found substantial biomarker-based evidence linking e-cigarette exposure to DNA damage, oxidative stress, and tumor growth markers.
Why the Cancer Count Is Still Zero on Paper
Cancer is fundamentally a disease of accumulated damage over time. Cigarette smoking typically takes 20 to 30 years of exposure before lung cancer rates climb noticeably in a population. E-cigarettes have been commercially available for roughly 15 years, with heavy adoption beginning only around 2014-2016 among younger users. That timeline is simply too short for population-level cancer data to emerge, even if vaping does cause cancer. The absence of confirmed cases right now tells you more about biology’s clock than about the safety of the product.
Researchers studying this question rely instead on surrogate evidence: carcinogen levels in vapor, biomarker measurements in vapers’ blood and urine, DNA damage in cells and tissues, gene expression changes, and animal experiments. Taken together, these streams of evidence paint a picture that is far from reassuring, even if they cannot yet deliver a body count.
What Vapers Are Actually Inhaling
E-cigarette vapor is not water vapor, despite that persistent myth. It contains measurable levels of toxic and carcinogenic substances, though at concentrations far lower than those found in cigarette smoke. One widely cited analysis found that toxicant levels in e-cigarette vapor were 9 to 450 times lower than in cigarette smoke, with many compounds present at trace levels comparable to a clean reference product.1PubMed Central. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes That ratio matters: “far less than a cigarette” is not the same as “harmless.” It means the dose is lower, not absent.
The heating process is where many of these compounds originate. When propylene glycol and vegetable glycerin are heated by the coil, they can break down into carbonyl compounds like formaldehyde, acetaldehyde, and acrolein, all of which are known carcinogens or irritants.2PubMed Central. Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury How much of these compounds you get depends heavily on the device and how it is used.
Device Settings Change the Risk Profile Dramatically
Not all vaping is equal from a toxicology standpoint. The temperature of the heating coil is the single biggest variable controlling how many harmful carbonyls end up in each puff. Research has shown a steep increase in carbonyl production when coil power reaches about 15 watts or higher, corresponding to coil temperatures of roughly 200-250°C. Even at the lowest tested wattage of 5 watts, the formaldehyde concentration per puff already exceeded a short-term indoor air guideline. Acrolein, a particularly concerning irritant, was only detected at 20 watts and above.3PubMed. Correlation of volatile carbonyl yields emitted by e-cigarettes with the temperature of the heating coil and the perceived sensorial quality of the generated vapours
Coil material and age also matter. The relationship between coil resistance and carbonyl output is not straightforward: some carbonyls form primarily through heat-driven degradation chemistry, while others form through pathways initiated by reactive oxygen species, and these two groups respond differently to the same coil settings.4PubMed Central. Carbonyls and Aerosol Mass Generation from Vaping Nicotine Salt Solutions Using Fourth- and Third-Generation E-Cigarette Devices: Effects of Coil Resistance, Coil Age, and Coil Metal Material High-wattage, sub-ohm devices popular among hobbyist vapers push more power through the coil, and analyses of cancer potency from emissions have associated the highest-risk results with excessive power delivered to the atomizer coil.5Tobacco Control. Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke In practical terms, cranking up the wattage for bigger clouds does not just produce more vapor; it produces qualitatively different vapor with higher concentrations of harmful byproducts.
Metals From the Coil Itself
Beyond the chemicals formed from heating e-liquid, the coil hardware introduces its own hazard. Most e-cigarette heating elements contain nichrome, an alloy of nickel and chromium. Both metals leach into the liquid and the aerosol. Nickel is classified as a Group 1 carcinogen (meaning there is sufficient evidence it causes cancer in humans), and chromium in its hexavalent form is similarly dangerous. Research has confirmed that e-cigarettes are a meaningful source of toxic metal exposure, with concentrations in some devices high enough to raise concern.6PubMed Central. E-cigarettes as a source of toxic and potentially carcinogenic metals
Risk modeling using reported metal concentrations in e-liquids and aerosols has produced some alarming numbers. Using US Environmental Protection Agency benchmarks, cancer risks from chromium and nickel in e-cigarettes exceeded the threshold generally considered acceptable, even at average reported concentrations. At the upper end of the reported range, the estimated cancer risk from chromium alone reached levels well above those thresholds.7PubMed Central. Cancer and Non-Cancer Risk Concerns from Metals in Electronic Cigarette Liquids and Aerosols A more recent review confirmed that the average carcinogenic risks from chromium and nickel via e-cigarette use exceeded acceptable ranges, and noted that inhaling these metals poses a higher overall risk than skin or oral exposure.8PubMed Central. Electronic cigarette-derived metals: exposure and health risks in vapers These are modeled risks based on measured concentrations, not observed cancer cases. But they suggest the metal exposure alone is not trivial.
What Biomarkers in Vapers’ Bodies Actually Show
The most direct evidence about what vaping does inside the body comes from measuring carcinogen byproducts in vapers’ urine and saliva. Here, the picture has a clear and consistent shape: vapers carry measurably lower levels of most carcinogen metabolites than cigarette smokers, but measurably higher levels of certain compounds than people who neither smoke nor vape.
A large US study spanning 2013 to 2019 found that cigarette smokers had dramatically higher levels of NNAL, a metabolite of a tobacco-specific carcinogen, compared to nicotine vapers. Vapers’ NNAL levels did not differ from those of people who used neither product.9JAMA. Trends in Urinary Biomarkers of Exposure to Nicotine and Carcinogens Among Adult e-Cigarette Vapers vs Cigarette Smokers in the US, 2013-2019 Other research has confirmed that several key carcinogen metabolites are significantly lower in e-cigarette users than in smokers, leading researchers to conclude that e-cigarettes have a more favorable toxicity profile on these measures.10Nicotine & Tobacco Research. Evaluation of Toxicant and Carcinogen Metabolites in the Urine of E-Cigarette Users Versus Cigarette Smokers A meta-analysis pooling multiple studies confirmed this pattern across a range of compounds, with smokers showing higher levels of most measured carcinogen biomarkers compared to e-cigarette users.11PubMed Central. Comparison of bladder carcinogenesis biomarkers in the urine of traditional cigarette users and e-cigarette users
The less reassuring side of this data concerns what happens when you compare vapers to people who use nothing at all. A study specifically examining bladder carcinogens found that two cancer-linked aromatic amines, o-toluidine and 2-naphthylamine, were present at roughly 2.3 and 1.3 times higher concentration in e-cigarette users’ urine compared to non-users.12Scientific Reports. Comparison of Bladder Carcinogens in the Urine of E-cigarette Users Versus Non E-cigarette Using Controls A systematic review concluded that biomarkers of several carcinogens strongly linked to bladder cancer are indeed present in vapers’ urine, and that the long-term implications for the bladder lining are unknown but concerning.13PubMed. Carcinogen Biomarkers in the Urine of Electronic Cigarette Users and Implications for the Development of Bladder Cancer: A Systematic Review
DNA Damage and Epigenetic Changes
Biomarker levels tell you what chemicals are circulating. The next question is whether those chemicals are actually damaging cells in ways that lead to cancer. Several lines of evidence say yes, at least at the cellular and molecular level.
Lab studies comparing e-cigarette aerosol to cigarette smoke on cells have found that cigarette smoke clearly causes dose-dependent DNA damage, while e-cigarette aerosol at equivalent or even much higher doses did not induce the same damage in one controlled comparison.14PubMed Central. The comparative in vitro assessment of e-cigarette and cigarette smoke aerosols using the γH2AX assay and applied dose measurements But other research on oral cells tells a different story. Studies on oral tissue have found DNA strand breaks, formation of micronuclei (a marker of chromosome damage), and upregulation of genes associated with cancer pathways in cells exposed to e-cigarette vapor.15PubMed Central. E-cigarette: a safe tool or a risk factor for oral cancer? A systematic review One review noted that e-cigarette users in some studies showed more metanuclear anomalies in oral cells than even cigarette smokers, while other studies showed smokers with higher acrolein-related DNA damage than vapers.16PubMed Central. The use of E-cigarettes as a risk factor for oral potentially malignant disorders and oral cancer: a rapid review of clinical evidence The inconsistency between different tissues and different studies is itself revealing: it suggests the risk is real but not uniform, varying with the tissue type, the device, the liquid, and the exposure pattern.
Perhaps the most striking recent finding involves epigenetic changes. A study of over 3,500 tissue samples found that cigarette smoking causes specific DNA methylation changes at certain genetic sites associated with cancer signaling pathways. Some of these same methylation patterns were elevated in cancer tissue and in lung lesions progressing toward cancer. Critically, these same changes were also hypermethylated in e-cigarette users who had limited smoking history.17PubMed Central. Cigarette Smoking and E-cigarette Use Induce Shared DNA Methylation Changes Linked to Carcinogenesis The researchers described this as “alarming” because it suggests vaping may be activating some of the same molecular switches that eventually drive smoking-related cancers. A separate epigenetic study, however, found that vapers’ overall methylation profiles looked more like non-smokers than like smokers, and that established smoking-related methylation patterns were not enriched in the vaping group.18PubMed Central. Investigating the DNA methylation profile of e-cigarette use These two studies are not necessarily contradictory: one looked at specific cancer-related sites and found shared changes, while the other looked at the genome-wide pattern and found the overall signature was distinct. But they illustrate why “does vaping cause cancer?” is not yet answerable with a clean yes or no.
What the Mouse Study Found
The most attention-grabbing animal experiment to date exposed mice to e-cigarette smoke for 54 weeks. About 22.5% of the exposed mice developed lung adenocarcinomas, a type of lung cancer. None of the mice breathing filtered air developed lung tumors. The same study found that over half the e-cigarette-exposed mice developed hyperplastic changes to bladder tissue, a potential precursor to bladder cancer, compared to almost none in the control groups.19AJMC. Exposure to e-Cigarette Smoke Associated With Lung Cancer in Mice
Mouse studies have obvious limitations: the doses, breathing patterns, and biology differ from human vaping. But this study was significant because it demonstrated that e-cigarette aerosol, by itself and without any prior tobacco exposure, could induce actual tumors in a living organism. That is a qualitatively different kind of evidence from biomarker measurements or cell-culture experiments.
The Dual-Use Problem
One of the biggest headaches in studying vaping and cancer is that most vapers are current or former smokers. Separating the cancer risk of vaping from the residual or ongoing risk of smoking is extremely difficult in epidemiological data. A study examining lung cancer risk found that people who both vaped and smoked had a roughly fourfold higher odds of lung cancer compared to those who only smoked, even after adjusting for pack-years of cigarette use.20PubMed Central. Vaping, Smoking and Lung Cancer Risk That finding is provocative but must be interpreted carefully: it comes from a database study where confounding factors are hard to fully control, and people who both vape and smoke may differ from smokers-only in ways not captured by the data. Still, it raises the uncomfortable possibility that adding vaping to smoking does not merely maintain existing risk but may accelerate it.
For the question most people actually care about, what matters is the population of never-smokers who vape. That group is growing, especially among younger adults, but it is still too small and too recently exposed for cancer cases to have materialized in detectable numbers. The 2025 systematic review specifically noted finding no significant cancer risk in never-smoker vapers, while acknowledging that the evidence base remains limited.21PubMed Central. Evidence update on the cancer risk of vaping e-cigarettes: A systematic review
Nicotine’s Own Role
A common misconception is that nicotine itself is the carcinogen in cigarettes. Nicotine is not classified as a carcinogen. However, it is not biologically inert when it comes to cancer either. Research has demonstrated that nicotine can promote cell proliferation, stimulate the growth of new blood vessels that tumors need to expand, and make cancer cells more resistant to dying when they should.22PubMed Central. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers These effects do not mean nicotine starts cancer, but they suggest it could help existing pre-cancerous changes progress faster. Since e-cigarettes deliver nicotine as their core purpose, this tumor-promoting activity is relevant even if the carcinogen load from vaping is lower than from smoking.23PubMed. Nicotine: specific role in angiogenesis, proliferation and apoptosis
EVALI Was a Different Problem
The 2019 outbreak of vaping-associated lung injuries scared millions of people and reshaped public perception of e-cigarettes almost overnight. But EVALI was not cancer, and it was not caused by standard nicotine e-cigarettes. The primary culprit was vitamin E acetate used as a cutting agent in black-market THC vape cartridges. When inhaled, lung tissue cannot metabolize or clear vitamin E acetate, and its accumulation triggered acute inflammatory lung injury.2PubMed Central. Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury
The reason this matters for the cancer question is that EVALI dramatically shifted how the public perceives all vaping. Research tracking social media during the outbreak found a significant spike in tweets about negative health outcomes like acute lung injury, though positive sentiment toward vaping actually remained high even at the peak.24PubMed Central. Using a mixed methods approach to identify public perception of vaping risks and overall health outcomes on Twitter during the 2019 EVALI outbreak Many people came away from EVALI believing that standard nicotine vaping had been shown to destroy lungs. That conflation persists and muddies the conversation about the actual long-term concern, which is cancer from chronic nicotine e-cigarette use rather than acute poisoning from adulterated THC products.
Flavoring Chemicals and Underexplored Risks
Beyond the base liquids and the hardware, the flavoring additives in e-liquids introduce their own set of concerns that are less well studied. One compound that has drawn particular attention is pulegone, a chemical found naturally in mint and used in mint- and menthol-flavored e-liquids. Pulegone is classified as a possible carcinogen based on animal data, and the FDA banned its use as a food additive in 2018, yet it remains present in e-liquids.
A risk analysis found that for e-liquids with the highest pulegone concentrations, the margin of exposure fell well below the safety threshold of 10,000, meaning the exposure level is close enough to the dose that causes harm in animals to raise concern. Depending on how much liquid someone uses daily, their pulegone exposure from vaping could be 44 to over 1,600 times higher than what a menthol cigarette smoker gets.25JAMA Internal Medicine. Risk Analysis for the Carcinogen Pulegone in Mint- and Menthol-Flavored e-Cigarettes and Smokeless Tobacco Products A separate analysis of popular mint and menthol products from brands like JUUL and Puff found that mint-labeled products tended to have higher pulegone concentrations than menthol-labeled ones, and that most exposure scenarios for mint-flavored products produced safety margins below the threshold.26Tobacco Control. Flavour chemicals, synthetic coolants and pulegone in popular mint-flavoured and menthol-flavoured e-cigarettes Pulegone is just one chemical among thousands of flavoring compounds used in e-liquids, most of which have been tested for safety when swallowed but not when inhaled repeatedly into the lungs.
Oral Cancer as a Specific Concern
The mouth and throat are the first tissues to encounter e-cigarette aerosol, making oral cancer one of the more closely watched potential outcomes. Experimental studies on oral cell lines have shown DNA strand breaks after exposure to e-cigarette vapors, and gene expression changes associated with cancer pathways have been identified in oral tissues exposed to vapor, both with and without nicotine present.27PubMed Central. Reviewing the oral carcinogenic potential of E-cigarettes using the Bradford Hill criteria of causation An RNA analysis of vapers’ oral cells found increased numbers of deregulated gene transcripts, and bioinformatic analysis identified molecular pathways in vapers that overlap with pathways responsible for tumor development in smoking-related cancers.16PubMed Central. The use of E-cigarettes as a risk factor for oral potentially malignant disorders and oral cancer: a rapid review of clinical evidence
No clinical oral cancer cases have been attributed to vaping in humans. But the cellular and molecular evidence is accumulating faster here than for other cancer sites, largely because oral tissue is the easiest to biopsy and study in living vapers. Whether these early molecular changes will translate into actual tumors over the coming decades is the question researchers cannot yet answer.
What Secondhand Exposure Looks Like
People worried about cancer from vaping sometimes also worry about bystanders. The data here is relatively reassuring compared to secondhand cigarette smoke. E-cigarettes emit nicotine into surrounding air but at concentrations roughly a tenth of what cigarette smoking produces. Combustion toxicants, the primary carcinogens in secondhand tobacco smoke, were not detected in secondhand e-cigarette vapor in controlled chamber studies.28PubMed Central. Secondhand Exposure to Vapors From Electronic Cigarettes That does not mean zero risk, particularly in poorly ventilated spaces with heavy use, but the secondhand cancer concern from vaping appears to be on a fundamentally different scale than from cigarettes.